The CHEK2 1100delC variant in Swedish colorectal cancer
2006 (English)In: Anticancer Research, ISSN 0250-7005, Vol. 26, no 6C, 4885-4888 p.Article in journal (Refereed) Published
Background: The cell cycle checkpoint kinase 2 (CHEK2) 1100delC variant has recently been identified at high frequency in families with both breast and colorectal cancer, suggesting the possible role of this variant in colorectal cancer predisposition. Patients and Methods: To evaluate the role of CHEK2 1100delC among Swedish colorectal cancer patients, the variant frequency was determined in 174 selected familial cases, 644 unselected cases and 760 controls, as well as in 18 families used in the genome-wide linkage analysis, where weak linkage was seen for the region harboring the CHEK2 gene. Results: CHEK2 1100delC was found in 1.15% of familial and in 0.93% of unselected cases, compared to 0.66% of controls, showing no significant difference between groups. One out of 45 familial cases with a family history of breast cancer was shown to be a carrier. The variant was not identified in the 18 families included in the linkage analysis. Conclusion: The CHEK2 1100delC was not significantly increased in Swedish colorectal cancer patients, however, in order to determine the role of the variant in colorectal cancer families with the history of breast cancer a larger sample size is needed.
Place, publisher, year, edition, pages
2006. Vol. 26, no 6C, 4885-4888 p.
CHEK2, colorectal cancer
Medical and Health Sciences
IdentifiersURN: urn:nbn:se:uu:diva-11843ISI: 000243083600038PubMedID: 17214356OAI: oai:DiVA.org:uu-11843DiVA: diva2:39612